Goal-orientated cognitive rehabilitation for dementias associated with Parkinson's disease?A pilot randomised controlled trial

Authors
Category Primary study
JournalINTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
Year 2018
ObjectiveTo examine the appropriateness and feasibility of cognitive rehabilitation for people with dementias associated with Parkinson's in a pilot randomised controlled study. MethodsThis was a single-blind pilot randomised controlled trial of goal-oriented cognitive rehabilitation for dementias associated with Parkinson's. After goal setting, participants were randomised to cognitive rehabilitation (n=10), relaxation therapy (n=10), or treatment-as-usual (n=9). Primary outcomes were ratings of goal attainment and satisfaction with goal attainment. Secondary outcomes included quality of life, mood, cognition, health status, everyday functioning, and carers' ratings of goal attainment and their own quality of life and stress levels. Assessments were at 2 and 6months following randomisation. ResultsAt 2months, cognitive rehabilitation was superior to treatment-as-usual and relaxation therapy for the primary outcomes of self-rated goal attainment (d=1.63 and d=1.82, respectively) and self-rated satisfaction with goal attainment (d=2.04 and d=1.84). At 6months, cognitive rehabilitation remained superior to treatment-as-usual (d=1.36) and relaxation therapy (d=1.77) for self-rated goal attainment. Cognitive rehabilitation was superior to treatment as usual and/or relaxation therapy in a number of secondary outcomes at 2months (mood, self-efficacy, social domain of quality of life, carers' ratings of participants' goal attainment) and at 6months (delayed recall, health status, quality of life, carer ratings of participants' goal attainment). Carers receiving cognitive rehabilitation reported better quality of life, health status, and lower stress than those allocated to treatment-as-usual. ConclusionsCognitive rehabilitation is feasible and potentially effective for dementias associated with Parkinson's disease.
Epistemonikos ID: daedd63f657ce2720027da91fa8f8e5fb3d04ce0
First added on: May 07, 2022